Tolmetin

Tolmetin (CAS No.: 26171-23-3) is an orally active, potent nonsteroidal anti-inflammatory drug, primarily known for its role as a cyclooxygenase (COX) inhibitor. This compound targets the COX-1 and COX-2 enzymes and exhibits low micromolar activity in in vitro experiments, with IC50 values of 0.35 μM and 0.82 μM, respectively. As a member of the nonsteroidal anti-inflammatory class of compounds, Tolmetin’s mechanism of action involves inhibiting the synthesis of prostaglandins, a process that plays a key role in inflammation and pain pathways. Tolmetin is widely used in biomedical research as an important tool for studying COX-related signaling pathways and the mechanisms of inflammatory responses. Its applications include cellular models and animal models. In drug discovery and screening programs, the effectiveness of Tolmetin as a COX inhibitor provides key insights into the pharmacodynamics of nonsteroidal anti-inflammatory drugs, helping to develop innovative compounds with improved anti-inflammatory properties. The concentrations or doses used in experiments are typically determined according to specific study designs and objectives, while consistently emphasizing its role as a benchmark for studying COX-related biological processes.